Boston Scientific | BSX - Gewinn Vor Steuern

Aktienkurs
57.17
Täglich Wechseln
-1.28 -2.19%
Monatlich
-9.15%
Jährlich
-44.43%
Q2 Prognose
60.74




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Danaher USD 1.24B 138M 2026-03
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Illumina USD 220M 86M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12